- (-%)
Range - - -   (-%)
Open -
Previous Close 0.330
Buy Price 0.315
Buy Volume 1
Sell Price 0.355
Sell Volume 1
Volume -
Value -
Measurement Type Value
EPS (SGD) 0.024
Trailing EPS (SGD) 0.024
NAV (SGD) 0.534
Cash In Hand (SGD) 0.061
Dividend 0.009
Dividend Yield (%) 2.368
PE 15.814
Trailing PE 15.813
Price / NAV 0.711
Price / Cash In Hand 6.281
Issued & Paid-up Shares 255,301,000
Treasury Shares 12,224,000
Market Cap (M) 97.014
Par Value (SGD) n.a.
Beta - 75 Days 0.388
R-Squared - 75 Days(%) 3.01
Beta - 500 Days 0.393
R-Squared - 500 Days(%) 1.44
ISIN Code SG2E64980112
Under CPF Investment Scheme (CPFIS) Yes
Index Components FTSE ST Fledgling
Delayed prices. Updated at 30 Sep 2022 17:16.
Data powered by
View All Events

About Cordlife

Cordlife Group Limited is an investment holding company engaged in the provision of cord blood banking services, which involves the processing and storage of stem cells. The Company operates as a consumer healthcare company. Its segments include Banking, Diagnostic and Others. The banking segment comprises cord blood and cord lining services. The diagnostics segment comprises Metascreen, which is a metabolic screening test specially designed for newborn babies, non-invasive prenatal testing service, and Eyescreen, a noninvasive pediatric eye-screening service. The cord blood and cord lining are collected, processed and stored in the various laboratories in the regions that the Company operates in. The Company also releases cord blood units for transplants, and for the treatment of cerebral palsy, as well as for other therapeutic uses. It has processing and cryopreservation storage facilities across Asia, namely in Singapore, Hong Kong, India, Indonesia, Malaysia and the Philippines.

Loading Chart...